Citigroup Inc Durect Corp Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.38 - $0.64 $1,950 - $3,284	-5,132 Reduced 63.09%	3,002 $1,000
Q1 2022 May 12, 2022	SELL	$0.55 - $0.98 $27,239 - $48,535	-49,526 Reduced 85.89%	8,134 $5,000
Q4 2021 Feb 10, 2022	BUY	$0.9 - $1.31 $1,170 - $1,703	1,300 Added 2.31%	57,660 $57,000
Q3 2021 Nov 10, 2021	BUY	$1.21 - $1.61 $68,195 - $90,739	56,360 New	56,360 $72,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.